Stopping medication after reaching a weight goal will very likely lead to weight re-gain, especially if those important lifestyle habits have not been implemented
These are on-target effects -- the same receptor activation that suppresses appetite and lowers blood glucose also causes GI symptoms
While other weight-loss medications target one or two of these gut hormones, retatrutide hits all three: GLP-1 & GIP: These hormones stimulate insulin release, slow digestion to keep you full, and target the appetite center in the brain to reduce cravings
The TR-1 assembly is exactly the same
Injectable tirzepatide and semaglutide reach peak blood levels quickly, sometimes triggering more pronounced nausea, while oral formulations have lower bioavailability and may be better tolerated during initiation, though they require larger pill burdens and more frequent dosing
Under FDA's stated interpretation, no